Cargando…

A Review of Low-Density Lipoprotein-Lowering Diets in the Age of Anti-Sense Technology

This narrative review discusses an important issue, the primary role of diet in reducing low-density lipoprotein cholesterol (LDLc) concentrations in polygenic hypercholesterolemia. Two effective drugs, statins, and ezetimibe, that lower LDLc > 20% are relatively inexpensive and potential competi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nestel, Paul J., Mori, Trevor A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005665/ https://www.ncbi.nlm.nih.gov/pubmed/36904248 http://dx.doi.org/10.3390/nu15051249

Ejemplares similares

Low-density lipoprotein cholesterol lowering treatment: the current approach
por: Crismaru, Irina, et al.
Publicado: (2020)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

High-Density Lipoproteins and Mediterranean Diet: A Systematic Review
por: Grao-Cruces, Elena, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus
por: Bays, Harold E
Publicado: (2014)

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
por: Packard, Chris, et al.
Publicado: (2021)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Lipoprotein(a) Removal Still a Mystery
por: Nestel, Paul
Publicado: (2019)

Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs
por: Harisa, Gamaleldin I., et al.
Publicado: (2013)

Significant Impact of the Ketogenic Diet on Low-Density Lipoprotein Cholesterol Levels
por: Salas Noain, Jesus, et al.
Publicado: (2020)

Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
por: Calvier, Laurent, et al.
Publicado: (2022)

Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome
por: Biswas, Hope H., et al.
Publicado: (2015)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
por: Ballantyne, Christie M., et al.
Publicado: (2022)

Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab
por: Shapiro, Michael D., et al.
Publicado: (2019)

Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Khan, Safi U., et al.
Publicado: (2019)

Oxidized low density lipoprotein, stem cells, and atherosclerosis
por: Yang, Hui, et al.
Publicado: (2012)

Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins
por: Fang, William H., et al.
Publicado: (2023)

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
por: Szarek, Michael, et al.
Publicado: (2020)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study
por: Bouillon, Kim, et al.
Publicado: (2011)

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
por: Lin, Yun, et al.
Publicado: (2010)

Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
por: Abdalwahab, Ahmed, et al.
Publicado: (2021)

Low High-Density Lipoprotein and Risk of Myocardial Infarction
por: Ramirez, A., et al.
Publicado: (2015)

Does Lowering Low‐Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle‐Aged Adults? Analysis of the Observational MESA Study
por: Liu, Kiang, et al.
Publicado: (2021)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

Low Levels of Low-Density Lipoprotein Cholesterol and Endothelial Function in Subjects without Lipid-Lowering Therapy
por: Takaeko, Yuji, et al.
Publicado: (2020)

Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
por: Chu, Chih-Sheng, et al.
Publicado: (2020)

Selective uptake of boronated low-density lipoprotein in melanoma xenografts achieved by diet supplementation.
por: Setiawan, Y., et al.
Publicado: (1996)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

The Ketogenic Diet: Breath Acetone Sensing Technology
por: Alkedeh, Omar, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases
por: Betzler, Bjorn Kaijun, et al.
Publicado: (2020)

Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
por: Wang, Qinqin, et al.
Publicado: (2020)

Low-Density Lipoproteins Oxidation and Endometriosis
por: Polak, Grzegorz, et al.
Publicado: (2013)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review
por: Anusheel,, et al.
Publicado: (2022)

Larrea divaricata: anti-inflammatory and antioxidant effects of on macrophages and low density lipoproteins
por: Peralta, Ignacio, et al.
Publicado: (2022)

Molecular, Population, and Clinical Aspects of Lipoprotein(a): A Bridge Too Far?
por: Ward, Natalie C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n4bb9g3utphpmqlaj359gvrmsi